Same‐day and rapid initiation of antiretroviral therapy in people living with HIV in Asia. How far have we come?
Year: 2022
Type: review
Abstract: Human immunodeficiency virus (HIV) continues to be a major public health issue, and the effectiveness of HIV prevention, diagnosis, treatment, and care varies, particularly in the Asia-Pacific region. The rapid initiation of antiretroviral therapy (ART) is important to control the HIV epidemic and to optimize the health of people living with HIV; many guidelines now recommend ART initiation within 7 days of HIV diagnosis, with same-day initiation for people diagnosed with HIV who feel ready. Many countries in the Asia-Pacific region have already implemented or are moving towards implementation of rapid or same-day ART initiation. However, there are many obstacles and challenges to its implementation, which vary substantially across the region. This article summarizes the latest evidence on rapid and same-day ART initiation and discusses lessons learned and barriers to implementation in Asian countries, particularly focusing on Taiwan, Thailand, Singapore, and the Republic of Korea.
Source: HIV Medicine
DOI: 10.1111/hiv.13410
Authors: Chien‐Ching Hung, Nittaya Phanuphak, Chen Seong Wong, Dariusz Piotr Olszyna, Tae Hyong Kim
Institutions: National Taiwan University, China Medical University, China Medical University Hospital, National Taiwan University Hospital, National University of Singapore, Tan Tock Seng Hospital, National Centre for Infectious Diseases, National University Hospital, National University Health System, Soonchunhyang University
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,650
Funder: Gilead Sciences
OpenAlex ID: W4306678277